Does a GLP-1 Solution Work? What the Evidence Says (October 2026)

01 · The core answer

Does a GLP-1 solution actually work?

A prescribed GLP-1 medicine works for most people who take it as directed, with a reduced-calorie diet and increased physical activity. The honest caveat is that 'GLP-1 solution' is not a medical term. The phrase is used for very different products, and whether it works depends entirely on which one you mean.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, and individual results vary. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

That is a different category from low-cost supplements sold as a natural alternative. If a product promises dramatic weight-loss claims, treat that as a warning sign. Our guide to a GLP-1 supplement and how it works goes into that comparison, and GLP-1 solution reviews explains how to read product claims.

02 · Is this for you?

Is it relevant to you, and what should you do next?

It is relevant if you are an adult looking for medically supervised weight management and you meet the licensed criteria, which a prescriber assesses. Tirzepatide is licensed in the UK for weight management in adults and for type 2 diabetes.¹ It is not a shortcut, and it is not suitable for everyone, which is why a clinician review matters.

There are two decisions most readers face. The first is whether to pursue treatment through the NHS or privately. Mounjaro is available on the NHS, but access is being phased in over several years, so many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁴ The second is what to expect once you start.

If you want to see how a regulated route works, our weight loss clinic explains the process, and the Mounjaro pen page shows current availability: all doses are in stock. The starting 2.5mg pen has a standard price of £169.99 per month, and a new customer's first 2.5mg pen costs £129.99 with code FIRST40. The consultation is free and reviewed by a GPhC-registered prescriber, so you can find out whether treatment is suitable before you pay.

03 · What the term means

What people mean by a 'GLP-1 solution'

The phrase 'GLP-1 solution' has no single definition, so the first step is to work out what is actually being sold. In practice it usually refers to one of three things: a prescription injectable medicine, a prescription tablet, or an over-the-counter product marketed as if it were one of those. Only the first two are licensed medicines assessed by regulators.

A licensed injectable such as Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ Wegovy is a semaglutide pen with its own dose ladder, and liraglutide products are a different, daily injection. Prescription tablets exist too, such as Wegovy tablets and Foundayo; they are different medicines from Mounjaro.

The third group is where confusion and risk sit. A low-cost supplement with no clinical oversight is not a GLP-1 medicine, does not go through a prescriber, and does not have a dosing schedule agreed by a regulator. Dosing is not standardised, and the products are not interchangeable with licensed treatment. Our page on how a GLP-1 supplement works covers that distinction in detail.

A simple test helps. Ask whether the product needs a consultation and a prescription, whether it names an active ingredient and strength, and whether it comes with a patient information leaflet. A genuine prescription medicine does all three. Mounjaro is a prescription-only medicine supplied only after a consultation reviewed by a GPhC-registered prescriber.¹³ Anything offering to supply it without a consultation or prescription should be avoided, and you can check any pharmacy against the GPhC register.¹²

If you read an advert that sounds too good, look at what it leaves out. Honest treatment information mentions diet, activity, side effects and that results vary. Our guide to reading GLP-1 solution reviews shows what to look for, and the GLP-1 solution overview sets out the terms side by side.

None of this means that supplements are dangerous in every case. It means they are a different decision, with a different level of evidence, and they should not be chosen on the assumption that they work the way a prescribed medicine does.

04 · How it works

How GLP-1 medicines work in the body

GLP-1 medicines work by copying or enhancing gut hormones that regulate appetite, digestion and the way the body handles blood sugar. GLP-1 itself is a natural hormone released after eating. Medicines in this class act on the same receptor, which is why people often feel fuller sooner and less hungry between meals.

Mounjaro adds a second mechanism. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹

The practical point is that the medicine changes the conditions in which you eat; it does not eat for you. Many people describe a quieter appetite, which makes smaller portions easier to sustain. That is why the licence pairs treatment with a reduced-calorie diet and increased physical activity.²

Another useful point concerns how long the medicine stays in the body. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹ That helps explain why effects build steadily on a weekly dose and fade gradually after stopping, rather than switching on and off.

You will sometimes read that GLP-1 works through 'food noise' or cravings. That is a common way of describing reduced appetite drive, and it matches the experience many people report. If you want the wider picture across the drug class, see our guide to how GLP-1 drugs work.

Because stomach emptying slows, Mounjaro can reduce how well oral contraceptive pills are absorbed.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If you take insulin or a sulfonylurea, doses may need adjusting because of the risk of low blood sugar, so tell the prescriber about every medicine you use.¹¹

05 · What trials show

What the trial evidence shows

The best-known evidence for tirzepatide in weight management is SURMOUNT-1, a large trial in adults. People taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, so they do not predict your own result.

The same trial reported how many people reached meaningful thresholds. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight.² Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² Notice the framing: these describe groups, and people vary in how they respond, which dose they reach and how well they tolerate it.

For a worked example of what a percentage means, someone starting at 100 kg who matched the 20.9% average would lose about 21 kg. That is straight arithmetic on a trial average, not a forecast, and it applies to people who stayed on the higher dose with lifestyle changes for the full trial period.

Wegovy has its own trial, STEP 1, and the liraglutide product Saxenda has a different profile again. Different trials in different groups cannot be read as a head-to-head contest, so their numbers should not be set side by side. The one trial that compares tirzepatide directly with semaglutide is SURMOUNT-5.¹⁵

In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.¹⁴ Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.

So, does it work? On average, yes, and by a margin that lifestyle changes alone did not match in the trial. But 'on average' hides a range, and some people respond more slowly or to a different dose. If you are curious how this compares with food-based approaches, our page on whether a GLP-1 diet works addresses the common misconceptions.

06 · Pace and three months

How fast do results come, and what about three months?

Weight loss on a GLP-1 medicine is gradual by design, so the fast results you may see online are not typical. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.² Trials measured results at 72 weeks — think in months, not days, and judge progress by trend, not individual weigh-ins.²

People often ask how much they can lose in three months. Three months in, most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures: in SURMOUNT-1, average weight loss built month by month, with the full 15–21% averages measured at 72 weeks, not 12.² A sensible 3-month expectation on a standard titration is mid single digits as a percentage of body weight, with wide individual variation.² Slower early progress does not predict failure — the dose you respond to may still be ahead of you.²

Why do some people seem to lose weight so fast? Part of the answer is water weight. The 2.5mg starting weeks are about adjustment, and experiences differ widely: some people notice appetite change and early loss in week one, others feel little until a higher dose — both are normal.² Early loss includes water weight, so the trend over weeks matters more than any single weigh-in.² Fast results shared online are also the ones people choose to share, so they are a poor guide to your own pace.

Your prescriber reviews response. If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.² That is the safety net: treatment is judged on evidence in your own case, not on hope.

The best way to track this is with a steady routine: weigh at the same time under similar conditions, record the trend, and compare month with month. Our free companion app, GLPTrackr, is designed for tracking a GLP-1 journey, though a notebook works too.

07 · Not losing weight

Why am I not losing weight on GLP-1?

The most common reasons are that it is still early, that the dose has not reached the level that works for you, or that eating and activity habits have drifted. A lack of progress at a given moment is not the same as the treatment not working, and the first step is to look at the trend over weeks rather than days.

Weight loss on Mounjaro is not linear — plateaus of a few weeks are normal and expected as the body adapts to a lower weight.² Within the licence, the responses are: review food intake honestly (portions drift back up), protect protein and activity, check the basics (sleep, alcohol), and discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.² A plateau is not a reason to double doses or add unlicensed products.²

Let us turn that into a practical checklist. Start with food. Keep an honest record for a short stretch and compare it with your plan.

Then consider protein and movement. Eating enough protein and staying active supports the kind of weight loss you want, and activity is part of the licence, not an optional extra. Sleep and alcohol are worth checking too.

Next, check your dose and timing. If you are still on a lower strength, the dose that gives you the best response may be ahead of you. The licensed pen sizes run from 2.5mg to 15mg, and each step is a considered change rather than a quick fix.¹

Finally, think about whether you are expecting the wrong pace. Because measurable progress builds from 5mg onward and trials ran for 72 weeks, a few slow weeks early on are very common.² If you are using a product sold as a 'solution' that is not a prescription medicine, the honest answer may be that it does not work like one at all. In that case, a consultation to discuss a licensed route is the sensible step.

08 · Health beyond the scales

Health benefits beyond weight, and questions about age and belly fat

Weight is only one of the measures prescribers care about, and in trials the changes went further than the scales. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not promises — but they are why prescribers talk about weight management as health management rather than appearance.²

That framing matters when you ask what works for belly fat. People often ask what kills the most belly fat, or how an older woman can lose it. No medicine or food has been shown to target fat in one area of the body. What the trial evidence does show is an average improvement in waist size alongside overall weight loss, which is a different thing from spot reduction.²

The same caution applies to the common questions about the hardest age to lose weight or the age at which people gain the most. A prescriber looks at your health, medicines, goals and history, and the licence is for adults.¹

For older adults in particular, a prescriber review matters more, not less. They will consider other conditions and medicines, including anything that affects blood sugar, and they will want you to eat enough protein and stay active. If you take insulin or a sulfonylurea, doses may need adjusting because of the risk of low blood sugar.¹¹

Side effects are part of the picture too. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.² If a symptom is severe or does not settle, speak to your prescriber, and you can report suspected side effects through the MHRA Yellow Card scheme. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting; pain in the upper right abdomen, fever or yellowing of skin/eyes; or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.¹⁹

So the realistic benefit is a package: gradual weight loss, often with improvements in waist size, blood pressure, cholesterol and blood-sugar measures on average, delivered through supervised treatment with diet and activity at the centre. Where a product promises something more dramatic or more targeted, ask what evidence sits behind it.

09 · GLP-1 versus Mounjaro

Is GLP-1 the same as Mounjaro?

No: GLP-1 is a hormone and a drug class, and Mounjaro is one specific medicine that acts on that hormone's receptor and a second one. When someone says they are 'on GLP-1', they might mean semaglutide, liraglutide, tirzepatide or a tablet, so it is worth being specific about which.

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly.¹ It is described as a dual GIP and GLP-1 medicine, which distinguishes it from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹

Liraglutide, sold as Saxenda and in products such as Erly, is supplied at 6mg/ml and is a daily injection, unlike the once-weekly Mounjaro and Wegovy. Tablets such as Wegovy tablets and Foundayo are also GLP-1 type treatments, and each has its own product information.^20,21

SURMOUNT-5 is the first large head-to-head trial of tirzepatide and semaglutide for weight loss, so figures from different trials should not be compared.¹⁵ The practical differences are dosing frequency, how you tolerate the medicine, availability and cost. A prescriber can help you choose, and you can look at the Wegovy pen alongside the Mounjaro option if you are weighing both.

On cost, the starting Mounjaro pen has a standard price of £169.99 per month, and a first order is £40 less with code FIRST40. Every later order is £25 off the standard price. Wegovy's first pen starts from £99.99 on a first order.

The key point is that asking whether 'GLP-1' works is like asking whether 'antibiotics' work. It depends which one, for what, and in whom.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · NHS, private and safety

Getting treatment safely: NHS, private and counterfeit risks

You can access Mounjaro through the NHS or through regulated private care, and the safest route is whichever one involves a real clinical assessment. Mounjaro is available on the NHS, but access is being phased in over several years.⁴ NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).^4,6 Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you ask your GP, you will be assessed against the current local criteria. If you choose private treatment, a regulated online pharmacy should offer a free consultation reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

Safety starts with supply. Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber.¹³ Be wary of anyone offering to supply without a consultation or prescription, and of prices that look far too low. The MHRA publishes counterfeit medicine alerts, and you can report suspected fake products or side effects through the Yellow Card scheme.^7,19 You can verify any UK pharmacy on the GPhC register; ours is registration 9012878.¹²

Our supply comes from official LillyDirect, direct from Eli Lilly's UK distribution, with genuine KwikPens and all doses from 2.5mg to 15mg stocked. Delivery is free, next-day and tracked in temperature-controlled packaging, and same-day dispatch applies when you order by 3pm. Saturday delivery is £14.99. Needles, a sharps bin and injection guidance come with every order.

Ordering has a simple path: complete the free online consultation, have it reviewed by a prescriber, then we dispense and dispatch. Repeat orders re-check suitability, and there is no auto-shipping. Monthly reviews and dose-titration support are included, and the team is on hand Monday to Friday, 9am to 5pm, at support@everydaymeds.co.uk or 0333 207 0413. Our prices are checked 10 October 2026; at standard prices, a first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg, with a new customer's first order £40 less and every later order £25 less.

Ready to see whether you are suitable? Start with the Mounjaro pen consultation. Mounjaro is used alongside a reduced-calorie diet and increased physical activity, individual results vary, and this page is information, not a substitute for medical advice.¹³